|
Originally published In Press as doi:10.1074/jbc.M405079200 on July 19, 2004
J. Biol. Chem., Vol. 279, Issue 39, 40419-40430, September 24, 2004
Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype*
Tamio Yamaguchi ,
Darren P. Wallace ,
Brenda S. Magenheimer ,
Scott J. Hempson ,
Jared J. Grantham , and
James P. Calvet ¶
From the
Departments of Biochemistry and Molecular Biology and Internal Medicine, the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas 66160
cAMP can be either mitogenic or anti-mitogenic, depending on the cell type. We demonstrated previously that cAMP inhibited the proliferation of normal renal epithelial cells and stimulated the proliferation of cells derived from the cysts of polycystic kidney disease (PKD) patients. The protein products of the genes causing PKD, polycystin-1 and polycystin-2, are thought to regulate intracellular calcium levels, suggesting that abnormal polycystin function may affect calcium signaling and thus cause a switch to the cAMP growth-stimulated phenotype. To test this hypothesis, we disrupted intracellular calcium mobilization by treating immortalized mouse M-1 collecting duct cells and primary cultures of human kidney epithelial cells with calcium channel blockers and by lowering extracellular calcium with EGTA. Calcium restriction for 35 h converted both cell types from a normal cAMP growth-inhibited phenotype to an abnormal cAMP growth-stimulated phenotype, characteristic of PKD. In M-1 cells, we showed that calcium restriction was associated with an elevation in B-Raf protein levels and cAMP-stimulated, Ras-dependent activation of B-Raf and ERK. Moreover, the activity of Akt, a negative regulator of B-Raf, was decreased by calcium restriction. Inhibition of Akt or phosphatidylinositol 3-kinase also allowed cAMP-dependent activation of B-Raf and ERK in normal calcium. These results suggest that calcium restriction causes an inhibition of the phosphatidylinositol 3-kinase/Akt pathway, which relieves the inhibition of B-Raf to allow the cAMP growth-stimulated phenotypic switch. Finally, M-1 cells stably overexpressing an inducible polycystin-1 C-terminal cytosolic tail construct were shown to exhibit a cAMP growth-stimulated phenotype involving B-Raf and ERK activation, which was reversed by the calcium ionophore A23187. We conclude that disruption of calcium mobilization in cells that are normally growth-inhibited by cAMP can derepress the B-Raf/ERK pathway, thus converting these cells to a phenotype that is growth-stimulated by cAMP.
Received for publication, May 7, 2004
, and in revised form, July 9, 2004.
* This work was supported by National Institutes of Health Grants DK53763, DK57301 (to J. J. G. and J. P. C.), and DK064756 (to D. P. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, the Kidney Institute, University of Kansas Medical Center, MS3030, Kansas City, KS 66160. Tel.: 913-588-7424; Fax: 913-588-7440; E-mail: jcalvet{at}kumc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. E. Torres
Type II Calcimimetics and Polycystic Kidney Disease: Unanswered Questions
J. Am. Soc. Nephrol.,
July 1, 2009;
20(7):
1421 - 1425.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Distefano, M. Boca, I. Rowe, C. Wodarczyk, L. Ma, K. B. Piontek, G. G. Germino, P. P. Pandolfi, and A. Boletta
Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1
Mol. Cell. Biol.,
May 1, 2009;
29(9):
2359 - 2371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Y. Park, Y. H. Sung, M. H. Yang, J. Y. Noh, S. Y. Park, T. Y. Lee, Y. J. Yook, K. H. Yoo, K. J. Roh, I. Kim, et al.
Cyst Formation in Kidney via B-Raf Signaling in the PKD2 Transgenic Mice
J. Biol. Chem.,
March 13, 2009;
284(11):
7214 - 7222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. BRAUN
Autosomal dominant polycystic kidney disease: Emerging concepts of pathogenesis and new treatments
Cleveland Clinic Journal of Medicine,
February 1, 2009;
76(2):
97 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, P. C. Harris, S. Somlo, D. Batlle, and V. E. Torres
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease
Nephrol. Dial. Transplant.,
February 1, 2009;
24(2):
526 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Montesano, H. Ghzili, F. Carrozzino, B. C. Rossier, and E. Feraille
cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells
Am J Physiol Renal Physiol,
February 1, 2009;
296(2):
F446 - F457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Alonso, E. Galibert, V. Boulay, A. Guillou, A. Jean, V. Compan, and G. Guillon
Sustained Elevated Levels of Circulating Vasopressin Selectively Stimulate the Proliferation of Kidney Tubular Cells via the Activation of V2 Receptors
Endocrinology,
January 1, 2009;
150(1):
239 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Muchatuta, V. H. Gattone II, F. A. Witzmann, and B. L. Blazer-Yost
Structural and Functional Analyses of Liver Cysts from the BALB/c-cpk Mouse Model of Polycystic Kidney Disease
Experimental Biology and Medicine,
January 1, 2009;
234(1):
17 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Wallace, M. T. Quante, G. A. Reif, E. Nivens, F. Ahmed, S. J. Hempson, G. Blanco, and T. Yamaguchi
Periostin induces proliferation of human autosomal dominant polycystic kidney cells through {alpha}V-integrin receptor
Am J Physiol Renal Physiol,
November 1, 2008;
295(5):
F1463 - F1471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pisitkun, V. Jacob, S. M. Schleicher, C.-L. Chou, M.-J. Yu, and M. A. Knepper
Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD
Am J Physiol Renal Physiol,
October 1, 2008;
295(4):
F1030 - F1043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-G. Ren, Z. Li, and D. B. Sacks
IQGAP1 Integrates Ca2+/Calmodulin and B-Raf Signaling
J. Biol. Chem.,
August 22, 2008;
283(34):
22972 - 22982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, I. B. M. Konings, J. Zhao, L. S. Price, E. de Heer, and P. M. T. Deen
Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2
Am J Physiol Renal Physiol,
August 1, 2008;
295(2):
F525 - F533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. E. Torres
Role of Vasopressin Antagonists
Clin. J. Am. Soc. Nephrol.,
July 1, 2008;
3(4):
1212 - 1218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Calvet
Strategies to Inhibit Cyst Formation in ADPKD
Clin. J. Am. Soc. Nephrol.,
July 1, 2008;
3(4):
1205 - 1211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Sweeney Jr, R. O. von Vigier, P. Frost, and E. D. Avner
Src Inhibition Ameliorates Polycystic Kidney Disease
J. Am. Soc. Nephrol.,
July 1, 2008;
19(7):
1331 - 1341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shibazaki, Z. Yu, S. Nishio, X. Tian, R. B. Thomson, M. Mitobe, A. Louvi, H. Velazquez, S. Ishibe, L. G. Cantley, et al.
Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1
Hum. Mol. Genet.,
June 1, 2008;
17(11):
1505 - 1516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Muller, M. Obeyesekere, G. B. Mills, and P. T. Ram
Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R
FASEB J,
May 1, 2008;
22(5):
1393 - 1403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Burtey, M. Riera, E. Ribe, P. Pennekamp, E. Passage, R. Rance, B. Dworniczak, and M. Fontes
Overexpression of PKD2 in the mouse is associated with renal tubulopathy
Nephrol. Dial. Transplant.,
April 1, 2008;
23(4):
1157 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lantinga-van Leeuwen, W. N. Leonhard, A. van der Wal, M. H. Breuning, E. de Heer, and D. J.M. Peters
Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice
Hum. Mol. Genet.,
December 15, 2007;
16(24):
3188 - 3196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ibraghimov-Beskrovnaya
Molecular pathogenesis of ADPKD and development of targeted therapeutic options
Nephrol. Dial. Transplant.,
December 1, 2007;
22(12):
3367 - 3370.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Ahrabi, S. Terryn, G. Valenti, N. Caron, C. Serradeil-Le Gal, D. Raufaste, S. Nielsen, S. Horie, J.-M. Verbavatz, and O. Devuyst
PKD1 Haploinsufficiency Causes a Syndrome of Inappropriate Antidiuresis in Mice
J. Am. Soc. Nephrol.,
June 1, 2007;
18(6):
1740 - 1753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Yoder
Role of Primary Cilia in the Pathogenesis of Polycystic Kidney Disease
J. Am. Soc. Nephrol.,
May 1, 2007;
18(5):
1381 - 1388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Leuenroth, D. Okuhara, J. D. Shotwell, G. S. Markowitz, Z. Yu, S. Somlo, and C. M. Crews
Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease
PNAS,
March 13, 2007;
104(11):
4389 - 4394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-N. T. Nguyen, D. P. Wallace, and G. Blanco
Ouabain Binds with High Affinity to the Na,K-ATPase in Human Polycystic Kidney Cells and Induces Extracellular Signal-Regulated Kinase Activation and Cell Proliferation
J. Am. Soc. Nephrol.,
January 1, 2007;
18(1):
46 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Magenheimer, P. L. St. John, K. S. Isom, D. R. Abrahamson, R. C. De Lisle, D. P. Wallace, R. L. Maser, J. J. Grantham, and J. P. Calvet
Early Embryonic Renal Tubules of Wild-Type and Polycystic Kidney Disease Kidneys Respond to cAMP Stimulation with Cystic Fibrosis Transmembrane Conductance Regulator/Na+,K+,2Cl- Co-Transporter-Dependent Cystic Dilation
J. Am. Soc. Nephrol.,
December 1, 2006;
17(12):
3424 - 3437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Obara, S. Mangos, Y. Liu, J. Zhao, S. Wiessner, A. G. Kramer-Zucker, F. Olale, A. F. Schier, and I. A. Drummond
Polycystin-2 Immunolocalization and Function in Zebrafish
J. Am. Soc. Nephrol.,
October 1, 2006;
17(10):
2706 - 2718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nagao, K. Nishii, M. Katsuyama, H. Kurahashi, T. Marunouchi, H. Takahashi, and D. P. Wallace
Increased Water Intake Decreases Progression of Polycystic Kidney Disease in the PCK Rat
J. Am. Soc. Nephrol.,
August 1, 2006;
17(8):
2220 - 2227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Li, M. Jerebtsova, X.-H. Liu, P. Tang, and P. E. Ray
Novel cystogenic role of basic fibroblast growth factor in developing rodent kidneys
Am J Physiol Renal Physiol,
August 1, 2006;
291(2):
F289 - F296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Calvet
MEK Inhibition Holds Promise for Polycystic Kidney Disease
J. Am. Soc. Nephrol.,
June 1, 2006;
17(6):
1498 - 1500.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Boca, G. Distefano, F. Qian, A. K. Bhunia, G. G. Germino, and A. Boletta
Polycystin-1 Induces Resistance to Apoptosis through the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway
J. Am. Soc. Nephrol.,
March 1, 2006;
17(3):
637 - 647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Porcellini, E. Traggiai, U. Schenk, D. Ferrera, M. Matteoli, A. Lanzavecchia, M. Michalak, and F. Grassi
Regulation of peripheral T cell activation by calreticulin.
J. Exp. Med.,
February 20, 2006;
203(2):
461 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang, R. S. Mitra, B. S. Henson, N. S. Datta, L. K. McCauley, P. Kumar, J. S.-J. Lee, T. E. Carey, and N. J. D'Silva
Rap1GAP Inhibits Tumor Growth in Oropharyngeal Squamous Cell Carcinoma
Am. J. Pathol.,
February 1, 2006;
168(2):
585 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamaguchi, S. J. Hempson, G. A. Reif, A.-M. Hedge, and D. P. Wallace
Calcium Restores a Normal Proliferation Phenotype in Human Polycystic Kidney Disease Epithelial Cells
J. Am. Soc. Nephrol.,
January 1, 2006;
17(1):
178 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Hooper, A. Boletta, G. G. Germino, Q. Hu, R. C. Ziegelstein, and M. Sutters
Expression of polycystin-1 enhances endoplasmic reticulum calcium uptake and decreases capacitative calcium entry in ATP-stimulated MDCK cells
Am J Physiol Renal Physiol,
September 1, 2005;
289(3):
F521 - F530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nagao, M. Kusaka, K. Nishii, T. Marunouchi, H. Kurahashi, H. Takahashi, and J. Grantham
Androgen Receptor Pathway in Rats with Autosomal Dominant Polycystic Kidney Disease
J. Am. Soc. Nephrol.,
July 1, 2005;
16(7):
2052 - 2062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Quarmby and J. D.K. Parker
Cilia and the cell cycle?
J. Cell Biol.,
June 6, 2005;
169(5):
707 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Kip, L. W. Hunter, Q. Ren, P. C. Harris, S. Somlo, V. E. Torres, G. C. Sieck, and Q. Qian
[Ca2+]i Reduction Increases Cellular Proliferation and Apoptosis in Vascular Smooth Muscle Cells: Relevance to the ADPKD Phenotype
Circ. Res.,
April 29, 2005;
96(8):
873 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, V. Gattone II, P. C. Harris, and V. E. Torres
Effectiveness of Vasopressin V2 Receptor Antagonists OPC-31260 and OPC-41061 on Polycystic Kidney Disease Development in the PCK Rat
J. Am. Soc. Nephrol.,
April 1, 2005;
16(4):
846 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhang, G. Zhang, M.S. Hayden, M.B. Greenblatt, C. Bussey, R.A. Flavell, S. Gosh, M. Leist, P. Ghezzi, G. Grasso, et al.
A Novel Molecule Designed to Keep Bacteria out of the Urinary Tract: A Toll-Like Receptor that Prevents Infection by Uropathogenic Bacteria. Science 303: 1522-1526, 2004
J. Am. Soc. Nephrol.,
January 1, 2005;
16(1):
4 - 7.
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|